Preventive oncology project for prostatic cancer
Watanabe, H.
Progress in Clinical and Biological Research 237: 133-142
1987
ISSN/ISBN: 0361-7742 PMID: 3317424 Document Number: 298226
Document emailed within 1 workday
Related Documents
Watanabe, H. 1983: Preventive medicine for prostatic cancer Gan no Rinsho. Japan Journal of Cancer Clinics 29(6): 527-531Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Glambek, I. 1982: Preventive antibiotic therapy in prostatic surgery Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 102(33): 1766-1767
Teni, T.R.; Bandivdekar, A.H.; Sheth, A.R.; Sheth, N.A. 1989: Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay Clinical Chemistry 35(7): 1376-1379
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258
Lowe, F.C.; Isaacs, J.T. 1984: Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model Cancer Research 44(2): 744-752
Vigada, G.; Malanetto, C. 1995: Role of microcolpohysteroscopy at an ambulatory center of level II preventive gynecologic oncology in the study of pre-neoplastic lesions of the uterine cervix Minerva Ginecologica 47(5): 183-187
Baranov, V.S. 2000: The human genome project as a scientific background of preventive medicine Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2000(10): 27-37
Stoica, O.; Azoicăi, D.; Ivan, A. 1995: The Human Genome Project and the outlook for preventive medicine. The bioethical implications Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 99(3-4): 13-16
Benvenuti, M.; Legnaioli, M.; Melone, F.; Taddei, I.; Tarquini, B. 1983: Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa) Chronobiologia 10(4): 383-386
Schubert, J.; Gorski, J. 1983: Zum biologischen Verhalten des Prostatakarzinoms. II: Klinisch-operative Studien zur lymphogenen Metastasierung des Prostatakarzinoms - Le comportement biologique du cancer prostatique. II: Etudes clinicochirurgicales sur les métastases lymphogènes du cancer prostatique - Biological behaviour of prostatic carcinoma. II. Clinical operative studies of lymphatic metastasizing of prostatic carcinoma der Urologe. Ausgabe a 22: 356-359
Plavetić, N.Dedić.; Dražin, R.Kelemenić.; Dintinjana, R.Dobrila.; Radić, M.; Prejac, J.; Dolić, Z.Mišetić.; Pavlović, M.; Škegro, M.; Šeparović, R.; Vrbanec, D. 2016: Cancer Patients Follow-Up – Croatian Society of Medical Oncology Clinical Guidelines Part Iii: Neuroendocrine Neoplasms, Hepatocellular Carcinoma, Pancreatic Cancer, Cancer of the Bile Ducts Lijecnicki vjesnik 138(7-8): 173-178
Jiang, J J.; Klein, G.; Discenza, R. 2002: Pre-project partnering impact on an information system project, project team and project manager European Journal of Information Systems 11(2): 86-97